FLAME 30
212 Reports in Biotechnology
2018 Biotechnology Research Review
Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis & includes highlights of reports published in 2018.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Ma...
The global liquid biopsy market should reach $6.1 billion by 2023 from $2.4 billion in 2018 at a compound annual growth rate (CAGR) of 20.8% for the period 2018 to 2023.
Emerging Jobs in Life Sciences and What You Should Be Training fo...
To develop and more importantly to improve current technologies, the market needs a pipeline of talent: well-educated and skilled scientists. Today, a new graduate or scientist with an immunology background will have a strong advantage in the market.The market for NGS applications reached $2.7 billion in 2016 and is expected to expand to $10.5 billion by 2022.The expanding biotech market offers a variety of careers. In some cases, we need to be creative and see behind the obvious scientific path.
Genome Editing: Technologies and Global Markets
The global market for genome editing should grow from $1.4 billion in 2018 to $4.4 billion by 2023, with a compound annual growth rate (CAGR) of 25.7% for the period of 2018-2023.
Synthetic (Cultured) Meat: Technologies and Global Markets
The global synthetic (cultured) meat market should reach $19.8 million by 2027 from $16.3 million in 2022 at a compound annual growth rate (CAGR) of 4.0% for the period 2022-2027.
Metabolomics: Technologies and Global Markets
The global market for metabolomics should grow from $9.8 billion in 2018 to reach $17.1 billion by 2023 at a compound annual growth rate (CAGR) of 11.9% for the period of 2018-2023.
Protein Expression: Global Markets
The global market for protein expression should grow from $1.8 billion in 2017 to $3.1 billion by 2022 at a compound annual growth rate (CAGR) of 11.3% from 2017 through 2022.
Flow Cytometry: Products, Technologies and Global Markets
The global market for flow cytometry should grow from $4.6 billion in 2018 to $7.3 billion in 2023, growing at a compound annual growth rate (CAGR) of 9.7% from 2018 through 2023.
Cancer Cell Analysis, Instruments, Consumables and Reagents
The global market for cancer cell analysis should reach $10.8 billion by 2023 from $7.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.
Cell Separation and Characterization in Solid Tumors: Global Mark...
The global market for cell separation and characterization in solid tumors should grow from $1.8 billion in 2018 to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5% for the period of 2018-2023.
Bioprocess Optimization and Digital Bio-manufacturing: Global Mar...
The global market for bioprocess optimization and digital biomanufacturing will grow from nearly $26.5 billion in 2018 to nearly $40.5 billion by 2023 with a compound annual growth rate (CAGR) of 8.9% for the period of 2018-2023.
Biomarker Deals: Terms, Value and Trends, 2008-2018
Over the last decade, biomarker research has become one of the essential aspects not only of the in vitro diagnostics industry but an important component of the drug discovery and development process. Moreover, with the growing trend in personalized medicine and companion diagnostics, the use of biomarkers is becoming obligatory in management of certain diseases, such as cancer drug regimen.
Chromatography in Pharmaceuticals and Biotechnology: Global Marke...
The global market for chromatography instruments and reagents should grow from $9.8 billion in 2018 to $14.0 billion in 2023 at a compound annual growth rate (CAGR) of 7.3% from 2018 to 2023.
Cell-based Assays: Technologies and Global Markets
The global market for cell-based assays should grow from $20.1 billion in 2018 to $32.7 billion by 2023 at a compound annual growth rate (CAGR) of 10.2% from 2018 through 2023.
High Content Screening/Imaging: Technologies and Global Markets
The global market for high content screening/imaging should grow from $915.0 million in 2018 to reach $1.7 billion by 2023 at a compound annual growth rate (CAGR) of 13.1% for the period of 2018-2023.
Bioinformatics: Technologies and Global Markets
The global market for bioinformatics should grow from $6.4 billion in 2017 to reach $16.0 billion by 2022 at a compound annual growth rate (CAGR) of 20.0% for the period of 2017-2022.
Proteomics: Technologies and Global Markets
The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.
Protein Analysis: Subfocus on Oncoproteomics
The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.
Genetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Biomarkers: Technologies and Global Markets
The global market for biomarkers should grow from $78.9 billion in 2018 to $136.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.6% from 2018 through 2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
Global Markets for Enzymes in Industrial Applications
The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Current Research & Developments Status of Chimeric Antigen Recept...
The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.
Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...
Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.
Choose your License
16 Upcoming Reports in Biotechnology
Cancer Profiling and Pathways: Technologies and Global Markets
Report Includes
- An overview of the global market for cancer profiling and pathways
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Discussion of products in this market, newly emerging tools, diagnostics and therapeutics, and their impacts on the market
- Examination of evolving methods, such as microarray analysis, multiplex PCR, and quantitative real-time PCR, which are integral to deciphering molecular mechanisms involved in gene function, biological development, and disease progression, and are important tools in the discovery and development of new drug targets and diagnostic biomarkers
- Identifications of important cancer profiling techniques, market shares by types of products on the market, and market shares by company, as well as types of cancers and biomarkers
- Coverage of epigenetic, methylation, and miRNA products in development, products in clinical trials and currently marketed, and clinical-stage development products
- Company profiles of key players in the market
Cell Line and Membrane Market
Report Includes
- Identification of applications of cell lines in drug development, diagnostics, and molecular biology
- Description of advancements in cell lines for cancer-based therapies
- Details of CAR-T Cell and immune check point inhibitor therapy
- Comparative study of autologous vs allogenic cells manufacturing process
- Explanation of increasing adoption of cell line technologies in cell-based assay and surging demand of antibody production as a driving force to the cell line market
- Detailed profiles of the major vendors in the global cell line and membrane market
Current BioPrinting Prospects, and Future Innovations
Report Includes
- Comprehensive analysis of the bioprinting technologies and their trending applications in the market at a global scale
- Analyses of the global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Segmentation of the global market by technologies and products, notably instruments (bioprinters), reagents (bioinks), 3D cell culture products, and software and services
- Focus on the popular and emerging applications of bioprinting in the clinical and research domains
- Regional dynamics of bioprinting technologies covering North America, Europe and Other emerging markets including India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America etc.
- Discussion of new developments and new product launches in the global bioprinting market
- A relevant patent analysis
- Company profiles of market players in the industry
Exosome Diagnostics and Therapeutics: Global Markets
Report Includes
- An overview of the global market for exosome diagnostics and therapeutics
- A look into discovery, definition and nomenclature, components, and biogenesis and processing of exosomes
- Description of immunological compatibility, cargo capabilities and other intrinsic therapeutic activities of exosomes
- Details of isolation and detection techniques of exosome
- Examination of exosomal proteins and nucleic acids as diagnostic biomarkers
- Information on bioinformatics databases for exosome research and product development
- Company profiles of the prominent players
Cell Viability Assays and Consumables Market
Report Includes
- An overview of the global cell viability assays market
- Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Coverage of various type of products available in the cell viability assays market and potential application sectors across various industries
- Complete understanding of mode of working of various instruments such as automated cell counters, flow cytometers and spectrophotometers
- Discussion of surging advent of number of potential biomarkers candidates for cell-based assays and surging focus on developing cell-based therapeutics as a driving force to cell viability assays market
- Insights of regulatory framework and investment analysis in the North American region
- Detailed profiles of the major players of the industry
Validation, Calibration and Standardization in Life Sciences Market
Report Includes
- Country specific data and analysis for US, Canada, Germany, France, UK, Spain, China, India, Japan, and Australia
- Explanation of validation and calibration of instruments such as heap filters, pH meters, incubators, autoclaves, HPLC units, and GC units
- Discussion of ongoing research in treatments of various diseases and susceptibility of various microbes towards traditional medicines as driving factors to the industry
- Insight into the regulatory compliances in life science industry
- Detailed profile of major companies of the industry
Cell Harvesting Market
Report Includes
- Description of segments and dynamics of the cell harvesting market
- Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Characterization and quantification of market potential for cell harvesting by type of harvesting, procedure, end user, component/equipment and region
- A brief study and intact information about the market development, and future trends that can be useful for the organizations involved in
- Elaboration on the influence of government regulations, current technology, and the economic factors that will shape the future marketplace
- Key patents analysis and new product developments in cell harvesting market
- Assessment of the vendors landscape and company profiles of major market players
Global Tumor-specific Antigen Market
Report Includes
- An overview of the global market for tumor-specific antigen
- Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Coverage of various types of product available in the tumor-specific antigen market and discussion of their potential applications
- Complete understanding of oncofetal, oncoviral, overexpressed/accumulated, mutated, lineage restricted and idiotypic tumor-specific antigens
- Insights of the regulatory framework and policies and funding initiatives by the government for cancer research
- Details of advancements in antigen specific T-Cell therapy for cancer and innovation within the industry
- Detailed profiles of the major vendors in the global tumor-specific antigen market
Global Longevity and Anti-senescence Therapy market
Report Includes
- An overview of the global longevity and anti-senescence therapy market
- Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Detailed description of different therapies such as senolytic drug therapy, gene therapy, and immunotherapy
- Coverage of drugs, devices and technologies used in longevity and anti-senescence market
- Dossier of clinical trials and expected launch of anti-senescence products
- Insights of the regulatory framework and policies and funding initiatives by the government
- Detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market
